About: LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.47 (+1.08%)
LTPASXLTR Pharma Ltd
Carregando status da lista de acompanhamento…
LTR Pharma Ltd share price
LTP price activity
Último preço
$ 0,470
Variação (24h)
0,01 AUD (1,08%)
Volume
99.58K
Volume (média 4 sem.)
-
Abertura
$ 0,47
Variação do dia
$ 0,45 - $ 0,48
Fechamento anterior
$ 0,47
Último negócio
10 Sep, 5:58 am GMT+0
Atrasado
10 Sep, 5:58 am GMT+0
LTP price performance
-7,84%
5D
-1,05%
1M
-34,72%
YTD
-1,05%
1Y
Atrasado
10 Sep, 5:58 am GMT+0
quote.marketSignals